Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
16901 | 565 | 39.3 | 78% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
85 | 25913 | MULTIPLE SCLEROSIS//MULTIPLE SCLEROSIS JOURNAL//NEUROMYELITIS OPTICA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | UCLA MULTIPLE SCLEROSIS PROGRAM | Address | 6 | 100% | 1% | 4 |
2 | MULTIPLE SCLEROSIS PROGRAM | Address | 5 | 26% | 3% | 16 |
3 | POSTPARTUM ACTIVATION | Author keyword | 3 | 100% | 1% | 3 |
4 | COUSINS | Address | 3 | 60% | 1% | 3 |
5 | FDN EUGENE DEVIC EDMUS SCLEROSE PLAQUES | Address | 2 | 67% | 0% | 2 |
6 | NEUROIMMUNOL RD 31 | Address | 2 | 33% | 1% | 5 |
7 | LEUVEN FERTIL | Address | 1 | 100% | 0% | 2 |
8 | MS CATALONIA CEMCAT | Address | 1 | 50% | 0% | 2 |
9 | RELAPSING EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | Author keyword | 1 | 100% | 0% | 2 |
10 | LOWER MOTOR NEURONE DISEASE | Author keyword | 1 | 40% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | POSTPARTUM RELAPSES | 24 | 82% | 2% | 14 |
2 | PREGNANCY HORMONE ESTRIOL | 23 | 65% | 4% | 22 |
3 | GLATIRAMER ACETATE EXPOSURE | 9 | 83% | 1% | 5 |
4 | ASSISTED REPRODUCTION TECHNIQUE | 6 | 80% | 1% | 4 |
5 | PRIMS | 6 | 80% | 1% | 4 |
6 | HORMONE ESTRIOL | 5 | 63% | 1% | 5 |
7 | ALPHA 4 INTEGRIN INHIBITOR | 5 | 50% | 1% | 7 |
8 | MITOXANTRONE EXPOSURE | 4 | 67% | 1% | 4 |
9 | BETA LIGAND | 3 | 57% | 1% | 4 |
10 | T HELPER SUBSETS | 3 | 60% | 1% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Multiple sclerosis and pregnancy: therapeutic considerations | 2013 | 19 | 48 | 75% |
The need for a disease-specific prospective pregnancy registry for multiple sclerosis (MS) | 2015 | 1 | 63 | 57% |
Pregnancy, sex and hormonal factors in multiple sclerosis | 2014 | 7 | 77 | 64% |
What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature | 2011 | 36 | 28 | 79% |
Current recommendations for multiple sclerosis treatment in pregnancy and puerperium | 2013 | 5 | 50 | 96% |
Sex-related factors in multiple sclerosis susceptibility and progression | 2012 | 30 | 119 | 51% |
Effects of pregnancy and breastfeeding on the multiple sclerosis disease course | 2013 | 8 | 50 | 56% |
Female Gender and Reproductive Factors Affecting Risk, Relapses and Progression in Multiple Sclerosis | 2013 | 8 | 100 | 53% |
Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration | 2012 | 35 | 144 | 38% |
Female reproductive issues in multiple sclerosis | 2013 | 7 | 100 | 49% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | UCLA MULTIPLE SCLEROSIS PROGRAM | 6 | 100% | 0.7% | 4 |
2 | MULTIPLE SCLEROSIS PROGRAM | 5 | 26% | 2.8% | 16 |
3 | COUSINS | 3 | 60% | 0.5% | 3 |
4 | FDN EUGENE DEVIC EDMUS SCLEROSE PLAQUES | 2 | 67% | 0.4% | 2 |
5 | NEUROIMMUNOL RD 31 | 2 | 33% | 0.9% | 5 |
6 | LEUVEN FERTIL | 1 | 100% | 0.4% | 2 |
7 | MS CATALONIA CEMCAT | 1 | 50% | 0.4% | 2 |
8 | SECC NEUROINMUNOL ENFERMEDADES DESMIELINIZANTES | 1 | 40% | 0.4% | 2 |
9 | RD 31 | 1 | 27% | 0.5% | 3 |
10 | ANESTHESIA SERV 151 | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000162256 | EVANS IMMUNOL//HLTH SCI 304//LUPRON DEPOT |
2 | 0.0000111090 | KRISTIAN GERHARD JEBSEN MS//MULTIPLE SCLEROSIS EPIDEMIOLOGY//NORWEGIAN MULTIPLE SCLEROSIS COMPETENCE |
3 | 0.0000108887 | NEUROENDOCRINE BIOCHEM//NON FEMINIZING ESTROGENS//HUMAN BIOCHEM |
4 | 0.0000101169 | GLATIRAMER ACETATE//INTERFERON BETA//INTERFERON BETA 1B |
5 | 0.0000094239 | SPHINCTERIC DYSFUNCTION//QUALIVEEN//URINARY DISORDERS |
6 | 0.0000089977 | CSF CEREBROSPINAL FLUID//SOLUBLE VASCULAR CELL ADHESION MOLECULE 1 SVCAM 1//INTRAVENOUS METHYLPREDNISOLONE |
7 | 0.0000081347 | FAMILIAL MULTIPLE SCLEROSIS//PROGRAM NEUROPSYCHIAT GENOM//HLA DRB11501 |
8 | 0.0000070259 | DANISH REGISTER MULTIPLE SCLEROSIS//LUPOID SCLEROSIS//AUTOIMMUNE TAUTOLOGY |
9 | 0.0000064072 | LEWIS//F344//LEW |
10 | 0.0000061685 | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS//MYELIN OLIGODENDROCYTE GLYCOPROTEIN//EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS |